









Markets
/
Stocks
/
nasdaq-aapg
/

Ascentage Pharma Group International

AAPG

View Detailed Chart

37.200USD

+0.120+0.32%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

0.00Market Cap

--P/E TTM



Ascentage Pharma Group International

37.200

+0.120+0.32%

Overview Company Financials

Financials

Intraday

30m

Today

+0.32%

5 Days

-1.59%

1 Month

-13.19%

6 Months

+104.40%

Year to Date

0.00%

1 Year

0.00%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 2 analysts

BUY

Current Rating

29.000

Target Price

-22.04%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

Ascentage Pharma Group International

AAPG

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Ionis Pharmaceuticals Inc

IONS

Exact Sciences Corp

EXAS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(6)

Neutral(3)

Buy(3)

Indicators

Sell(3)

Neutral(3)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-1.226

Neutral

RSI(14)

48.205

Neutral

STOCH(KDJ)(9,3,3)

23.024

Neutral

ATR(14)

1.649

Low Volatility

CCI(14)

-114.290

Sell

Williams %R

77.695

Sell

TRIX(12,20)

0.209

Sell

StochRSI(14)

6.709

Oversold

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

38.210

Sell

MA10

38.602

Sell

MA20

39.093

Sell

MA50

34.900

Buy

MA100

28.290

Buy

MA200

26.097

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Ascentage Pharma Group International is a holding company primarily engaged in discovering, developing and commercializing therapies primarily in hematological malignancies. The Company’s main business is engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus and certain age-related diseases. The Company’s main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918 and other products. The Company’s products are mainly used to address the major hematological malignancies, including chronic myeloid leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, acute lymphocytic leukemia, myelodysplastic syndrome, and multiple myeloma. The Company mainly conducts its business in the domestic market.

Ticker SymbolAAPG

CompanyAscentage Pharma Group International

CEODr. Dajun Yang, M.D., Ph.D.

Websitehttps://www.ascentage.cn/